Skip to Main Content
Back to News

New Analyst Forecast: $ISRG Given 'Overweight' Rating

None

We just received data on a new analyst forecast for $ISRG. Piper Sandler gave a rating of 'Overweight' for $ISRG.

$ISRG Analyst Ratings

Wall Street analysts have issued reports on $ISRG in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Piper Sandler issued a "Overweight" rating on 04/23/2025
  • BTIG issued a "Buy" rating on 04/14/2025
  • UBS issued a "Overweight" rating on 01/29/2025
  • Citigroup issued a "Buy" rating on 01/24/2025
  • Morgan Stanley issued a "Overweight" rating on 01/16/2025
  • Bernstein issued a "Outperform" rating on 01/08/2025

To track analyst ratings and price targets for $ISRG, check out Quiver Quantitative's $ISRG forecast page.

$ISRG Price Targets

Multiple analysts have issued price targets for $ISRG recently. We have seen 4 analysts offer price targets for $ISRG in the last 6 months, with a median target of $622.5.

Here are some recent targets:

  • Ryan Zimmerman from BTIG set a target price of $560.0 on 04/14/2025
  • An analyst from Truist Financial set a target price of $605.0 on 03/17/2025
  • Patrick Wood from Morgan Stanley set a target price of $650.0 on 12/02/2024

$ISRG Congressional Stock Trading

Members of Congress have traded $ISRG stock 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $ISRG stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$ISRG Insider Trading Activity

$ISRG insiders have traded $ISRG stock on the open market 66 times in the past 6 months. Of those trades, 0 have been purchases and 66 have been sales.

Here’s a breakdown of recent trading of $ISRG stock by insiders over the last 6 months:

  • JAMIE SAMATH (EVP & CFO & Enterprise Technol) has made 0 purchases and 22 sales selling 31,285 shares for an estimated $16,809,860.
  • GARY S GUTHART (CEO) has made 0 purchases and 3 sales selling 25,591 shares for an estimated $13,085,803.
  • MYRIAM CURET (EVP & Chief Medical Officer) has made 0 purchases and 8 sales selling 23,306 shares for an estimated $12,655,297.
  • DAVID J. ROSA (President) has made 0 purchases and 2 sales selling 16,509 shares for an estimated $9,204,142.
  • ROBERT DESANTIS (EVP & Chief Strategy & Corp Op) has made 0 purchases and 15 sales selling 12,744 shares for an estimated $6,405,064.
  • BRIAN EDWARD MILLER (EVP & Chief Digital Officer) has made 0 purchases and 5 sales selling 12,900 shares for an estimated $6,365,341.
  • AMAL M JOHNSON sold 4,635 shares for an estimated $2,626,191
  • GARY LOEB (EVP & Chief Legal and Complian) has made 0 purchases and 3 sales selling 4,300 shares for an estimated $2,390,260.
  • MARK BROSIUS (SVP & Chief Mfg and Supply Cha) has made 0 purchases and 5 sales selling 2,457 shares for an estimated $1,368,015.
  • FREDRIK WIDMAN (VP Corporate Controller) sold 810 shares for an estimated $464,761
  • AMY L LADD sold 150 shares for an estimated $84,990

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$ISRG Hedge Fund Activity

We have seen 991 institutional investors add shares of $ISRG stock to their portfolio, and 800 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles